SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001477932-22-006948
Filing Date
2022-09-15
Accepted
2022-09-15 18:11:35
Documents
2
Period of Report
2022-07-25

Document Format Files

Seq Description Document Type Size
1 FORM 4 form4.html 4  
1 FORM 4 form4.xml 4 3940
2 POWER OF ATTORNEY curr_ex24.htm EX-24 7560
  Complete submission text file 0001477932-22-006948.txt   12995
Mailing Address 5805 SEPULVEDA BLVD., SUITE 801 SHERMAN OAKS CA 91411
Business Address 5805 SEPULVEDA BLVD., SUITE 801 SHERMAN OAKS CA 91411 424-273-8675
Cure Pharmaceutical Holding Corp. (Issuer) CIK: 0001643301 (see all company filings)

IRS No.: 371765151 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O CURE PHARMACEUTICAL HOLDING CORP. 5805 SEPULVEDA BLVD., SUITE 801 SHERMAN OAKS CA 91411
Business Address
BAGG GERALD (Reporting) CIK: 0001941325 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-55908 | Film No.: 221246632